Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License.

  • noun A humanized monoclonal antibody under investigation for the treatment of eosinophil-meditated inflammations of the airways, skin and gastrointestinal tract.

Etymologies

from Wiktionary, Creative Commons Attribution/Share-Alike License

-li- +‎ -zu- +‎ -mab

Support

Help support Wordnik (and make this page ad-free) by adopting the word reslizumab.

Examples

  • Cephalon was prompted to snap up Ception after taking a close look at new Phase II data for Cinquil (reslizumab), an experimental therapy for asthma.

    FierceBiotech John Carroll 2010

  • And that's really largely due to ramping-up of the programs, the starting of the hydrocodone, starting of the reslizumab in asthma and starting of the TNF in sciatica with an increased ramping-up enrollment in bipolar.

    SeekingAlpha.com: Home Page 2010

  • And then on reslizumab, we haven't really talked much about that and I think there are some extension data that - or an extension study that's ongoing.

    SeekingAlpha.com: Home Page 2010

  • Don't forget, there were two opportunities when we entered into our option agreement with reslizumab and Ception.

    SeekingAlpha.com: Home Page 2010

  • As anticipated in our yearly R&D guidance, we expected R&D expenses should increase in the second half of the year as enrollment in our LUPUZOR, reslizumab, anti-TNF domain antibody, and tamper-deterrent hydrocodone clinical programs increases.

    SeekingAlpha.com: Home Page 2010

  • Later this quarter, we expect to receive study results on reslizumab for the treatment of eosinophilic asthma.

    SeekingAlpha.com: Home Page 2010

  • Don't forget, there were two opportunities when we entered into our option agreement with reslizumab and Ception.

    SeekingAlpha.com: Home Page 2010

  • And then on reslizumab, we haven't really talked much about that and I think there are some extension data that - or an extension study that's ongoing.

    SeekingAlpha.com: Home Page 2010

  • 'We view the reslizumab failure as a significant setback,' William Tanner, an analyst at Lazard Capital Markets, said in a research note.

    unknown title 2009

  • 'We recommend assuming that reslizumab will not be filed for approval in EE without another trial, if ever.'

    unknown title 2009

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.